If you work in or around biotech, you're supposed to understand clinical trial results. But what if you're not an expert in study design or biostatistics? You may feel out of your comfort zone when faced with a journal article, press release, or investor presentation.
The Pharmagellan Guide to Analyzing Biotech Clinical Trials is a comprehensive primer to help non-experts evaluate clinical studies of new therapies.
If you're a biotech executive, investor, advisor, or entrepreneur - or aspire to be one - this handbook will give you the foundation you need to analyze planned and completed clinical trials with more confidence.